search
Back to results

Evaluation of Two Different Treatments for Lower Pore Renal Stone: Microperc Vs FURS

Primary Purpose

Surgery--Complications, Renal Calculus, Nephrolithiasis

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Microperc surgery
FURS
Sponsored by
Ningbo No. 1 Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Surgery--Complications focused on measuring FURS, microperc, renal calculus, Randomized Controlled Trial, Retrograde Intrarenal Surgery

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. 10-20mm lower pole renal stone measured by KUB or CT;
  2. Age between 18-60 years, no gender limitation;
  3. Participators can understand the research and sign the consent form without mental illness nor language disorder;
  4. Low pole renal stone left after lithotripsy;
  5. Lower pole infundibulopelvic angle which measured by IVP or CTU will less than 30 degree;
  6. Asymptomatic patients with positive urine white blood cells and negative preoperative urine culture should be treated with antibiotics for 3days before operation;
  7. Patients with symptoms of urinary infections, positive urine withe blood cells and positive preoperative urine culture should be treated with suitable antibiotics based on the culture sensitivity result for at least 7days before operation.

Exclusion Criteria:

  1. Transplant kidney stone;
  2. Renal malformations, such as UPJO, medullary sponge kidney, polycystic kidney, horseshoe kidney, etc.;
  3. Combine other part of urinary stones need to be handle at the same procedure, for example ureteral stone, renal pelvic stone, middle or upper pole renal stone;
  4. Hematological Disease or Coagulation disorders;
  5. Withdraw anticoagulant medicine less than two weeks;
  6. Fever or urinary infections without treatment according to the inclusion criteria;
  7. Sevier renal dysfunction(endogenous creatinine clearance rate≤50ml/min)
  8. Middle or severe hydronephrosis(dilatation of the renal pelvis ≥20mm by ultrasound);
  9. Women in menstrual period or pregnancy;
  10. Patients have severe disease, such as heart disease, lung dysfunction, and multiple organ failure that cannot tolerate anesthesia or operation.

Sites / Locations

  • Ningbo NO.1 hospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Microperc surgery

FURS

Arm Description

Patient is turned into prone position and the desired calyx is punctured by 4.8F microperc under fluoroscopic or sonographic guidance. No tract dilation is needed. A 200um holmium laser fiber will be used to break stone into less than 2mm. Pull out microperc without drainage tube left.

Patient is placed in the lithotomy position, pull out the pre-inserted double J, and place guidewire into the renal pelvis. A 12/14 Fr ureteral access sheath (UAS) is advanced into the proximal ureter over the guidewire, and flexible ureteroscope is passed through the UAS. The stones are fragmented smeller than 2mm using a 200um holmium laser fiber. Fragments are removed using a stone basket for stone analysis if necessary, a double J stent is placed at the conclusion of the procedure and removed post-operative 4 weeks.

Outcomes

Primary Outcome Measures

SFR
Stone free Rate

Secondary Outcome Measures

Complications
Complications after surgery
Duration of postoperative hospital stay
Duration of postoperative hospital stay
Postoperative pain
Postoperative pain,visual analogue scale(VAS)
The rate of hemoglobin decrease
The rate of hemoglobin decrease
Operation time
Operation time of surgery

Full Information

First Posted
September 30, 2017
Last Updated
November 16, 2017
Sponsor
Ningbo No. 1 Hospital
Collaborators
Beijing Friendship Hospital, Renmin Hospital of Wuhan University, Affiliated Hospital of Hebei University, Jiangsu Province Hospital of Traditional Chinese Medicine, West China Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, People's Hospital of Anshun City of Guizhou Province, Zhejiang Provincial People's Hospital, The First Affiliated Hospital with Nanjing Medical University, First Affiliated Hospital of Xinjiang Medical University, General Hospital of Shenyang Military Region
search

1. Study Identification

Unique Protocol Identification Number
NCT03307096
Brief Title
Evaluation of Two Different Treatments for Lower Pore Renal Stone: Microperc Vs FURS
Official Title
Evaluation of Two Different Treatments for Lower Pore Renal Stone: Microperc Vs FURS
Study Type
Interventional

2. Study Status

Record Verification Date
November 2017
Overall Recruitment Status
Unknown status
Study Start Date
November 17, 2017 (Anticipated)
Primary Completion Date
October 1, 2019 (Anticipated)
Study Completion Date
December 31, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ningbo No. 1 Hospital
Collaborators
Beijing Friendship Hospital, Renmin Hospital of Wuhan University, Affiliated Hospital of Hebei University, Jiangsu Province Hospital of Traditional Chinese Medicine, West China Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, People's Hospital of Anshun City of Guizhou Province, Zhejiang Provincial People's Hospital, The First Affiliated Hospital with Nanjing Medical University, First Affiliated Hospital of Xinjiang Medical University, General Hospital of Shenyang Military Region

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a prospect, randomized control trial to evaluate merits between microperc and FURS for lower pole renal stone
Detailed Description
To evaluate the merits of Microperc and RIRS for the treatment for lower pole renal stone between 10-20 mm. Investigators will do a multi-centers randomized controlled trial(RCT). A total of 200 (three hundred) patients, aging between 18 and 60 years are being planned to be enrolled into the study; By simple random sampling technique, patients will be prospectively randomized into group A and group B with a 1:1 ratio. Group A will receive the microperc surgery and group B will undergo FURS. All the patients will be diagnosed definitely before operations with non-contrast CT+IVP or CTU, lower pole Infundibular length, Infundibular width and Lower pole infundibulopelvic angle were recorded. A double J stent will be inserted in two the relevant ureter two weeks before surgery to guarantee the successful of operations. Patience will receive either microperic or FURS respectively, The operation time , hemoglobin change, renal function, post-operation pain, complications and hospital stay will be recorded. Patience will have follow-up visits at one month and three months, CT and KUB will be taken to evaluate the clearance of renal stone. Surgical technique Microperc surgery: After the satisfaction of anesthesia, Patient is turned into prone position and the desired calyx is punctured by 4.8F microperc under fluoroscopic or sonographic guidance. No tract dilation is needed. A 200um holmium laser fiber will be used to break stone into less than 2mm. Pull out microperc without drainage tube left; RIRS: After the satisfaction of anesthesia, the patient is placed in the lithotomy position, pull out the pre-inserted double J stent, and place guidewire into the renal pelvis. A 12/14 Fr ureteral access sheath (UAS) is advanced into the proximal ureter over the guidewire, and flexible ureteroscope is passed through the UAS. The stones are fragmented smeller than 2mm using a 200um holmium laser fiber. Fragments are removed using a stone basket for stone analysis if necessary, a double J stent is placed at the conclusion of the procedure and removed post-operative 2 weeks. Data collection Data for the 2 groups-demographic characteristics, hemoglobin(HB) decrease, white blood cell(WBC) increase, postoperative pain, duration of postoperative hospital stay, complications (modified Clavien system), stone clearance (SFR) and the need for auxiliary treatment are compared. Mean study endpoint: Final SFR (3 months after procedure) Secondary endpoint: Complications, duration of postoperative hospital stay. re-microperc, ureteroscopy and SWL are considered as auxiliary treatments. The stone size is defined as the maximum diameter as determined by CT scans. Degree of hydronephrosis are assigned as follow: none (no calyx or pelvic dilation), mild (pelvic dilatation alone), moderate (mild calyx dilation), or severe (severe calyx dilation or calyx dilation accompanied by renal parenchyma atrophy). Definition of operation time: For microperc: recorded from the time of the first percutaneous renal puncture to pulling out the microperc. For RIRS: recorded from insertion of an endoscope into the urethra to the completion of stent placement. Hospital stay are rounded to the nearest whole day and calculated from the day of surgery to the day of discharge. Postoperative pain (visual analogue scale(VAS), use of analgesics) will be recorded. The rate of hemoglobin decrease is assessed by comparing the preoperative Hb level with 24-hour postoperative Hb level. Non-contrast CT and KUB is obtained for all patients at 3 month after the operation to evaluate the final SFR, allowing time for the spontaneous passage of stone fragments. Stone-free status are defined as either the absence of any residual stone fragments or the presence of clinically insignificant residual stone fragments in the kidney which were defined as ≤4mm, asymptomatic, non-obstructive and non-infectious stone particles. Complications of all patients are recorded according to modified Clavien classification system.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgery--Complications, Renal Calculus, Nephrolithiasis, Urolithiasis
Keywords
FURS, microperc, renal calculus, Randomized Controlled Trial, Retrograde Intrarenal Surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
A total of 200 patients, aging between 18 and 60 years are enrolled into the study, patients will be prospectively randomized into group A and group B with a 1:1 ratio. Group A will receive the microperc surgery and group B will undergo FURS.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Microperc surgery
Arm Type
Experimental
Arm Description
Patient is turned into prone position and the desired calyx is punctured by 4.8F microperc under fluoroscopic or sonographic guidance. No tract dilation is needed. A 200um holmium laser fiber will be used to break stone into less than 2mm. Pull out microperc without drainage tube left.
Arm Title
FURS
Arm Type
Active Comparator
Arm Description
Patient is placed in the lithotomy position, pull out the pre-inserted double J, and place guidewire into the renal pelvis. A 12/14 Fr ureteral access sheath (UAS) is advanced into the proximal ureter over the guidewire, and flexible ureteroscope is passed through the UAS. The stones are fragmented smeller than 2mm using a 200um holmium laser fiber. Fragments are removed using a stone basket for stone analysis if necessary, a double J stent is placed at the conclusion of the procedure and removed post-operative 4 weeks.
Intervention Type
Procedure
Intervention Name(s)
Microperc surgery
Intervention Description
Parents are treated by Microperc Percutaneous Nephrolithotomy
Intervention Type
Procedure
Intervention Name(s)
FURS
Intervention Description
Parents are treated by FURS
Primary Outcome Measure Information:
Title
SFR
Description
Stone free Rate
Time Frame
3 month
Secondary Outcome Measure Information:
Title
Complications
Description
Complications after surgery
Time Frame
3 month
Title
Duration of postoperative hospital stay
Description
Duration of postoperative hospital stay
Time Frame
7 days
Title
Postoperative pain
Description
Postoperative pain,visual analogue scale(VAS)
Time Frame
3 month
Title
The rate of hemoglobin decrease
Description
The rate of hemoglobin decrease
Time Frame
7 days
Title
Operation time
Description
Operation time of surgery
Time Frame
12 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 10-20mm lower pole renal stone measured by KUB or CT; Age between 18-60 years, no gender limitation; Participators can understand the research and sign the consent form without mental illness nor language disorder; Low pole renal stone left after lithotripsy; Lower pole infundibulopelvic angle which measured by IVP or CTU will less than 30 degree; Asymptomatic patients with positive urine white blood cells and negative preoperative urine culture should be treated with antibiotics for 3days before operation; Patients with symptoms of urinary infections, positive urine withe blood cells and positive preoperative urine culture should be treated with suitable antibiotics based on the culture sensitivity result for at least 7days before operation. Exclusion Criteria: Transplant kidney stone; Renal malformations, such as UPJO, medullary sponge kidney, polycystic kidney, horseshoe kidney, etc.; Combine other part of urinary stones need to be handle at the same procedure, for example ureteral stone, renal pelvic stone, middle or upper pole renal stone; Hematological Disease or Coagulation disorders; Withdraw anticoagulant medicine less than two weeks; Fever or urinary infections without treatment according to the inclusion criteria; Sevier renal dysfunction(endogenous creatinine clearance rate≤50ml/min) Middle or severe hydronephrosis(dilatation of the renal pelvis ≥20mm by ultrasound); Women in menstrual period or pregnancy; Patients have severe disease, such as heart disease, lung dysfunction, and multiple organ failure that cannot tolerate anesthesia or operation.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yue Cheng, Dr.
Phone
13586689920
Email
dongbaba8@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Li Fnag, Dr.
Phone
17757461299
Email
fanyuro@126.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yue Cheng, Dr.
Organizational Affiliation
Ningbo No. 1 Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ningbo NO.1 hospital
City
Ningbo
State/Province
Zhejiang
ZIP/Postal Code
315010
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Liemin Ruan, MD
Phone
0086057487085111
First Name & Middle Initial & Last Name & Degree
Zhongze Lou, MD

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
24220692
Citation
Sener NC, Imamoglu MA, Bas O, Ozturk U, Goktug HN, Tuygun C, Bakirtas H. Prospective randomized trial comparing shock wave lithotripsy and flexible ureterorenoscopy for lower pole stones smaller than 1 cm. Urolithiasis. 2014 Apr;42(2):127-31. doi: 10.1007/s00240-013-0618-z. Epub 2013 Nov 13.
Results Reference
background
PubMed Identifier
17447057
Citation
Ozgur Tan M, Irkilata L, Sen I, Onaran M, Kupeli B, Karaoglan U, Bozkirli I. The impact of radiological anatomy in clearance of lower caliceal stones after shock wave lithotripsy. Urol Res. 2007 Jun;35(3):143-7. doi: 10.1007/s00240-007-0093-5. Epub 2007 Apr 20.
Results Reference
background
PubMed Identifier
16158878
Citation
Juan YS, Chuang SM, Wu WJ, Shen JT, Wang CJ, Huang CH. Impact of lower pole anatomy on stone clearance after shock wave lithotripsy. Kaohsiung J Med Sci. 2005 Aug;21(8):358-64. doi: 10.1016/S1607-551X(09)70134-2.
Results Reference
background
PubMed Identifier
27604704
Citation
Turk C. [Urolithiasis guidelines: retrospective view and perspectives]. Urologe A. 2016 Oct;55(10):1317-1320. doi: 10.1007/s00120-016-0230-2. German.
Results Reference
background
PubMed Identifier
24642147
Citation
Molina WR, Kim FJ, Spendlove J, Pompeo AS, Sillau S, Sehrt DE. The S.T.O.N.E. Score: a new assessment tool to predict stone free rates in ureteroscopy from pre-operative radiological features. Int Braz J Urol. 2014 Jan-Feb;40(1):23-9. doi: 10.1590/S1677-5538.IBJU.2014.01.04.
Results Reference
background
PubMed Identifier
9607435
Citation
Elbahnasy AM, Clayman RV, Shalhav AL, Hoenig DM, Chandhoke P, Lingeman JE, Denstedt JD, Kahn R, Assimos DG, Nakada SY. Lower-pole caliceal stone clearance after shockwave lithotripsy, percutaneous nephrolithotomy, and flexible ureteroscopy: impact of radiographic spatial anatomy. J Endourol. 1998 Apr;12(2):113-9. doi: 10.1089/end.1998.12.113.
Results Reference
background
PubMed Identifier
22840867
Citation
Resorlu B, Unsal A, Gulec H, Oztuna D. A new scoring system for predicting stone-free rate after retrograde intrarenal surgery: the "resorlu-unsal stone score". Urology. 2012 Sep;80(3):512-8. doi: 10.1016/j.urology.2012.02.072. Epub 2012 Jul 26.
Results Reference
result
PubMed Identifier
25923149
Citation
Kilicarslan H, Kaynak Y, Kordan Y, Kaygisiz O, Coskun B, Gunseren KO, Kanat FM. Unfavorable anatomical factors influencing the success of retrograde intrarenal surgery for lower pole renal calculi. Urol J. 2015 Apr 29;12(2):2065-8.
Results Reference
result
PubMed Identifier
21855968
Citation
Resorlu B, Oguz U, Resorlu EB, Oztuna D, Unsal A. The impact of pelvicaliceal anatomy on the success of retrograde intrarenal surgery in patients with lower pole renal stones. Urology. 2012 Jan;79(1):61-6. doi: 10.1016/j.urology.2011.06.031.
Results Reference
result
PubMed Identifier
25879676
Citation
Inoue T, Murota T, Okada S, Hamamoto S, Muguruma K, Kinoshita H, Matsuda T; SMART Study Group. Influence of Pelvicaliceal Anatomy on Stone Clearance After Flexible Ureteroscopy and Holmium Laser Lithotripsy for Large Renal Stones. J Endourol. 2015 Sep;29(9):998-1005. doi: 10.1089/end.2015.0071. Epub 2015 May 15.
Results Reference
result
PubMed Identifier
23826843
Citation
Sabnis RB, Ganesamoni R, Doshi A, Ganpule AP, Jagtap J, Desai MR. Micropercutaneous nephrolithotomy (microperc) vs retrograde intrarenal surgery for the management of small renal calculi: a randomized controlled trial. BJU Int. 2013 Aug;112(3):355-61. doi: 10.1111/bju.12164.
Results Reference
result
PubMed Identifier
25917724
Citation
Karatag T, Tepeler A, Silay MS, Bodakci MN, Buldu I, Daggulli M, Hatipoglu NK, Istanbulluoglu MO, Armagan A. A Comparison of 2 Percutaneous Nephrolithotomy Techniques for the Treatment of Pediatric Kidney Stones of Sizes 10-20 mm: Microperc vs Miniperc. Urology. 2015 May;85(5):1015-1018. doi: 10.1016/j.urology.2015.02.010.
Results Reference
result

Learn more about this trial

Evaluation of Two Different Treatments for Lower Pore Renal Stone: Microperc Vs FURS

We'll reach out to this number within 24 hrs